mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |